Back to search

University of Leeds

Statistical modelling of time to relapse or onset of metastatic disease following treatment for cancer: relationship to residual/resistant disease and re-growth

Abstract

dc:description.abstract

Response to treatment for some cancers may result in a proportion of the patients being permanently cured of the disease, while the rest remain at risk of a relapse or progression. Standard survival analysis approaches assume that all patients will eventually experience the event of interest and so are not appropriate in these situations. The residual disease and tumour re-growth rate following treatment are two of the important predictors of outcomes among cancer patients following treatment. However, in most cases, data on these measures is not always available. Using data from multiple myeloma and chronic lymphocytic leukaemia trials conducted at the Leeds Institute of Clinical Trials Research, we investigated the role of the residual disease and other important factors associated with time to relapse and overall survival, as well as the probability of being cured of the malignancy following treatment. As the multiple myeloma trial also collected data on bio-markers for tumour growth rate, we used the structural equation modelling approach to investigate the role of growth rate on the survival outcomes using available statistical software. We then extended these models to also investigate the association of growth and the probability of being cured after treatment in a Bayesian framework including in situations where not all patients will relapse or die after treatment. This work demonstrates that it is feasible to use structural equation modelling within survival analysis to investigate the role of latent variables on time to event outcomes even in situations where not all patients will relapse or die after treatment.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Leeds
Year dc:date.issued
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Musicha, Crispin
Advisors dc:contributor.advisor
  • Sharples, Linda
  • Cairns, David
  • Brown, Julia
ORCID person:identifier.orcid

Rights

Language dc:language.dcterms_iso639_2
eng

Identifiers

dc:identifier.*
Identifier
uk.bl.ethos.819316

Chain of custody

source
Harvested from
White Rose University Consortium
Base URL
etheses.whiterose.ac.uk/cgi/oai2
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Musicha, Crispin. Statistical modelling of time to relapse or onset of metastatic disease following treatment for cancer: relationship to residual/resistant disease and re-growth. doctoral thesis, University of Leeds, 2019.